Top News Stories
News
The opioid epidemic claims its first corporate victim
By Riley GriffinInsys Therapeutics could become the first corporate casualty of the opioid epidemic, collapsing under legal expenses and plummeting sales.
Insys Therapeutics could become the first corporate casualty of the opioid epidemic, collapsing under legal expenses and plummeting sales.